|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.032 USD | -25.58% |
|
-33.33% | +45.45% |
| Apr. 15 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
| Mar. 12 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
Cell MedX Corp. reported earnings results for the first quarter ended August 31, 2022. For the first quarter, the company reported sales was USD 0.000516 million compared to USD 0.001197 million a year ago.
Net loss was USD 0.154685 million compared to USD 0.239352 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +45.45% | 9.51M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CELL MEDX CORP. 
